Search results for: 'pacf infectious'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) covers insights across biomanufacturing, targeted drug delivery, imaging, precision medicine and biologics innovations.The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and ...

The COVID-19 pandemic accelerated the shift toward greater adoption of decentralized healthcare, building trust by demonstrating the feasibility and ease of testing at home and in pharmacies with accurate results, including self-sampling options. Increasing technological advancements have created several opportunities for market expansion in direct...

30 Oct 2024  |  Global  |  Market Research

Clinical Chemistry and Immunoassay Industry, Global, 2023?2028

Integrated and Scalable Core Lab Solutions Driving Transformational Growth

Infographics

×

This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to s...

The molecular diagnostics industry is undergoing consolidation, requiring capital investment and faster regulatory pathways to accelerate clinical adoption. Major diagnostics and life sciences companies are acquiring proprietary testing platforms to strengthen positions in precision oncology and blood-based diagnostics. AI-enabled genomic workflow ...

Biological systems are complex and involve several biological reactions and biomolecules. Understanding the biological reactions and identifying the associated biomolecules will help in the development of accurate diagnostics and aid precision medicine. Yet the high number of molecules often requires multiple tests or bulky instruments. To overcome...

27 Jan 2020  |  Global  |  Market Research

Growth Opportunities—Contract Manufacturing and Outsourcing Opportunities in the In-vitro Diagnostics (IVD) Industry, 2019 to 2022

Consolidation and Innovative Business Models Will Accelerate IVD Outsourcing Growth

Infographics

×

Key Issues Addressed

The increasing pressure for cost-driven development and regulatory and regional trends are inducing industry participants to adopt innovative integrated business models so as to align themselves as one-stop-shop solution providers as opposed to the traditional functional service providers, thereby, creating a mutually beneficial symbiotic relations...

15 Dec 2020  |  Global  |  Frost Radar

Frost Radar™: Advanced Antibodies, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Infographics

×

With advances in antibody-based therapies, bispecific antibodies (bsAbs) have gained momentum in the last few years after the regulatory approvals of Amgens blinatumomab (Blincyto®) and Chugais Hemlibra for Hemophilia A. The key advantage of bsAbs lies in their ability to bind two different epitopes or antigens, thereby overcoming the limitations o...

The US life sciences research tools market encompasses analytical tools, instruments, consumables, reagents, and services (e.g., X-rays and sample preparation). Tools include laboratory automation and technologies that provide molecular insight into disease mechanisms and enable novel therapeutic and medical device development to improve human heal...

The SynBio field has evolved well over the past two decades, with significant technology disruptions leading to new opportunities and remarkable growth potential. Advances in SynBio technologies have transformed drug discovery and therapeutics development, accelerating the identification of novel drug targets and high-throughput compound screening ...